chartexchange

EWTX
Edgewise Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:46 PM EST
41.35USD-1.641%(-0.69)866,833
Pre-marketNov 18, 2026 8:49:30 AM EST
42.05USD+0.024%(+0.01)
After-hoursNov 18, 2026 4:00:30 PM EST
41.37USD+0.048%(+0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Boulder, CO, USA
Previous Close
$42.04
Beta
1.15
52-Week High
$48.78 2026-11-09
52-Week Low
$19.76 2025-12-22
SMA 50
$41.31
SMA 200
$37.15
Avg. Vol 10D
2.08M
Avg. Vol 30D
1.60M
Avg. Vol 90D
1.43M
Relative Vol
0.54
109.48M
82.58M
12,696,203
0.2800%
2,300,000
226
EWTX Profile

edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed.

EWTX Performance
PeriodPriceDateChangeBeta
1W47.572026-11-11-13.03%2.081
1M37.922026-10-19+9.10%0.847
3M44.112026-08-18-6.21%0.809
6M31.722026-05-18+30.42%1.054
1Y22.162025-11-18+86.69%1.146
2Y30.792024-11-18+34.36%—
5Y20.952021-11-18+97.47%1.362
EWTX Stock Summary

Edgewise Therapeutics, Inc. Common Stock (NASDAQ:EWTX) stock price today is $41.37, and today's volume is 866,833. EWTX is down 1.594% today. The 30 day average volume is 1.60M. EWTX market cap is $4.53B with 109.48M shares outstanding.